US equities
|
SPCX
$163.13
▲+1.59%
TSLA
$384.90
▲+2.64%
MU
$1,039.52
▲+0.36%
AAPL
$332.78
▼-2.24%
NVDA
$230.92
▲+0.19%
AMD
$615.03
▼-0.91%
SNDK
$1,618.19
▲+0.54%
LITE
$1,096.64
▲+4.58%
SPCX
$163.13
▲+1.59%
TSLA
$384.90
▲+2.64%
MU
$1,039.52
▲+0.36%
AAPL
$332.78
▼-2.24%
NVDA
$230.92
▲+0.19%
AMD
$615.03
▼-0.91%
SNDK
$1,618.19
▲+0.54%
LITE
$1,096.64
▲+4.58%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Surgery Partners, Inc. - Common Stock
(NQ:
SGRY
)
13.74
+0.10 (+0.73%)
Delayed Quote
Updated: 10:00 AM EDT, Oct 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Surgery Partners, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
1 Russell 2000 Stock with Competitive Advantages and 2 Facing Headwinds
Today 0:34 EDT
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,...
Via
StockStory
Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes Stocks Trade Down, What You Need To Know
September 23, 2026
What Happened? A number of stocks fell in the afternoon session after sentiment in the healthcare sector weakened, as the Centers for Medicare and Medicaid S...
Via
StockStory
Surgery Partners (SGRY): Buy, Sell, or Hold Post Q2 Earnings?
September 23, 2026
Surgery Partners’s 30.8% return over the past six months has outpaced the S&P 500 by 12.8%, and its stock price has climbed to $15.67 per share. This was par...
Via
StockStory
Topics
Bankruptcy
Stocks
Surgery Partners Director Teresa DeLuca Buys 11,250 Shares
↗
September 03, 2026
As the stock price dips lower, this executive purchase shows confidence in the future of Surgery Partners.
Via
The Motley Fool
Topics
Regulatory Compliance
Surgery Partners Inc (NASDAQ:SGRY) Q1 2026 Results Show Narrower Loss and Revenue Beat, But Stock Dips
↗
May 05, 2026
Via
Chartmill
3 Cash-Producing Stocks Walking a Fine Line
August 27, 2026
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Via
StockStory
Surgery Partners (SGRY) Q2 2026 Earnings Call Transcript
↗
August 17, 2026
Idaho Falls sale signals shift to pure-play surgical focus.
Via
The Motley Fool
Topics
Earnings
The Top 5 Analyst Questions From Surgery Partners’s Q2 Earnings Call
August 17, 2026
Surgery Partners’ second quarter results were received positively by the market, with management highlighting that revenue and adjusted EBITDA came in ahead ...
Via
StockStory
Topics
Earnings
1 of Wall Street’s Favorite Stocks to Research Further and 2 We Avoid
August 14, 2026
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...
Via
StockStory
Outpatient & Specialty Care Stocks Q2 Highlights: Surgery Partners (NASDAQ:SGRY)
August 12, 2026
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the outpatient & specialty care stocks, including Surgery Partners (NASDAQ:SGRY) and it...
Via
StockStory
Topics
Artificial Intelligence
SGRY Q2 Deep Dive: Portfolio Optimization and Acuity Mix Lead Operating Shift
August 11, 2026
Healthcare company Surgery Partners (NASDAQ:SGRY) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 2.7% year on year to $848.9 million. Th...
Via
StockStory
Surgery Partners Q2 Earnings Call Highlights
↗
August 10, 2026
Surgery Partners (NASDAQ:SGRY) reported second-quarter 2026 revenue and adjusted EBITDA above its internal expectations, while reaffirming its full-year outlook ahead of the anticipated sale of its...
Via
MarketBeat
Topics
Earnings
Surgery Partners (NASDAQ:SGRY) Beats Q2 CY2026 Sales Expectations
August 10, 2026
Healthcare company Surgery Partners (NASDAQ:SGRY) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 2.7% year on year to $...
Via
StockStory
Surgery Partners (SGRY) Q2 Earnings: What To Expect
August 08, 2026
Healthcare company Surgery Partners (NASDAQ:SGRY) will be announcing earnings results this Monday before market hours. Here’s what to expect. Surgery Partner...
Via
StockStory
Topics
Artificial Intelligence
1 Profitable Stock for Long-Term Investors and 2 Facing Challenges
July 31, 2026
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Via
StockStory
3 Russell 2000 Stocks We Steer Clear Of
July 29, 2026
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resou...
Via
StockStory
1 Healthcare Stock to Target This Week and 2 We Brush Off
July 20, 2026
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as...
Via
StockStory
3 Stocks Under $50 with Warning Signs
July 10, 2026
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...
Via
StockStory
1 Cash-Producing Stock Worth Your Attention and 2 We Find Risky
July 06, 2026
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Via
StockStory
Why Surgery Partners (SGRY) Stock Is Trading Up Today
July 02, 2026
What Happened? Shares of healthcare company Surgery Partners (NASDAQ:SGRY) jumped 2.7% in the morning session after Cantor Fitzgerald reiterated its "Overwei...
Via
StockStory
Unpacking Q1 Earnings: Surgery Partners (NASDAQ:SGRY) In The Context Of Other Outpatient & Specialty Care Stocks
June 18, 2026
Looking back on outpatient & specialty care stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Surgery Partners (NASDAQ:SGRY...
Via
StockStory
Topics
Artificial Intelligence
3 Reasons to Sell SGRY and 1 Stock to Buy Instead
June 16, 2026
Surgery Partners currently trades at $15.10 per share and has shown little upside over the past six months, posting a small loss of 2.7%. The stock also fell...
Via
StockStory
Surgery Partners vs. Viemed Healthcare: Which Outpatient Care Stock Is a Better Buy in 2026?
↗
June 10, 2026
Outpatient surgery giant or home-based respiratory care leader, which business model stands out as healthcare spending patterns evolve and margins diverge?
Via
The Motley Fool
1 Small-Cap Stock to Keep an Eye On and 2 That Underwhelm
May 21, 2026
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...
Via
StockStory
3 of Wall Street’s Favorite Stocks Walking a Fine Line
May 18, 2026
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...
Via
StockStory
Topics
Economy
5 Revealing Analyst Questions From Surgery Partners’s Q1 Earnings Call
May 12, 2026
Surgery Partners’ first quarter saw revenue growth above Wall Street expectations, with management attributing performance to stability across its surgical f...
Via
StockStory
Topics
Earnings
3 Healthcare Stocks Walking a Fine Line
May 07, 2026
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged...
Via
StockStory
SGRY Q1 Deep Dive: Stable Margins and Physician Recruitment Offset Volume Headwinds
May 06, 2026
Healthcare company Surgery Partners (NASDAQ:SGRY) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 4.5% year on year to $8...
Via
StockStory
Surgery Partners SGRY Q1 2026 Earnings Transcript
↗
May 05, 2026
Surgery Partners SGRY Q1 2026 Earnings Transcript
Via
The Motley Fool
Surgery Partners’s (NASDAQ:SGRY) Q1 CY2026 Sales Beat Estimates
May 05, 2026
Healthcare company Surgery Partners (NASDAQ:SGRY) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 4.5% year on year to $...
Via
StockStory
Topics
Earnings
< Previous
1
2
3
4
5
6
7
8
9
Next >
